JP2016512044A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016512044A5 JP2016512044A5 JP2016502597A JP2016502597A JP2016512044A5 JP 2016512044 A5 JP2016512044 A5 JP 2016512044A5 JP 2016502597 A JP2016502597 A JP 2016502597A JP 2016502597 A JP2016502597 A JP 2016502597A JP 2016512044 A5 JP2016512044 A5 JP 2016512044A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- antigen
- specific
- optionally
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003719 b-lymphocyte Anatomy 0.000 claims 74
- 239000000427 antigen Substances 0.000 claims 71
- 102000036639 antigens Human genes 0.000 claims 71
- 108091007433 antigens Proteins 0.000 claims 71
- 210000004027 cell Anatomy 0.000 claims 25
- 238000000034 method Methods 0.000 claims 19
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 16
- 239000006228 supernatant Substances 0.000 claims 14
- 238000010186 staining Methods 0.000 claims 11
- 239000011324 bead Substances 0.000 claims 8
- 229960002685 biotin Drugs 0.000 claims 8
- 235000020958 biotin Nutrition 0.000 claims 8
- 239000011616 biotin Substances 0.000 claims 8
- 238000012258 culturing Methods 0.000 claims 8
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 claims 8
- 230000005764 inhibitory process Effects 0.000 claims 7
- 108010090804 Streptavidin Proteins 0.000 claims 6
- 230000006698 induction Effects 0.000 claims 6
- 238000002965 ELISA Methods 0.000 claims 5
- 238000000684 flow cytometry Methods 0.000 claims 5
- 239000011159 matrix material Substances 0.000 claims 5
- 229920001184 polypeptide Polymers 0.000 claims 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims 5
- 238000012216 screening Methods 0.000 claims 5
- 241000894007 species Species 0.000 claims 5
- 241000283973 Oryctolagus cuniculus Species 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 238000010187 selection method Methods 0.000 claims 4
- 239000007787 solid Substances 0.000 claims 4
- 210000001744 T-lymphocyte Anatomy 0.000 claims 3
- 239000011248 coating agent Substances 0.000 claims 3
- 238000000576 coating method Methods 0.000 claims 3
- 230000008014 freezing Effects 0.000 claims 3
- 238000007710 freezing Methods 0.000 claims 3
- 230000035755 proliferation Effects 0.000 claims 3
- 238000003757 reverse transcription PCR Methods 0.000 claims 3
- 238000005406 washing Methods 0.000 claims 3
- 101001098868 Homo sapiens Proprotein convertase subtilisin/kexin type 9 Proteins 0.000 claims 2
- 102100038955 Proprotein convertase subtilisin/kexin type 9 Human genes 0.000 claims 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000001185 bone marrow Anatomy 0.000 claims 2
- 239000003636 conditioned culture medium Substances 0.000 claims 2
- 230000005714 functional activity Effects 0.000 claims 2
- 230000003053 immunization Effects 0.000 claims 2
- 238000002649 immunization Methods 0.000 claims 2
- 210000001165 lymph node Anatomy 0.000 claims 2
- 239000002609 medium Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims 2
- 230000000704 physical effect Effects 0.000 claims 2
- 238000011176 pooling Methods 0.000 claims 2
- 238000003127 radioimmunoassay Methods 0.000 claims 2
- 239000012429 reaction media Substances 0.000 claims 2
- 210000000952 spleen Anatomy 0.000 claims 2
- 238000003860 storage Methods 0.000 claims 2
- 108090001008 Avidin Proteins 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 claims 1
- 102100025588 Calcitonin gene-related peptide 1 Human genes 0.000 claims 1
- 241000700199 Cavia porcellus Species 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 claims 1
- 241000238631 Hexapoda Species 0.000 claims 1
- 101001051093 Homo sapiens Low-density lipoprotein receptor Proteins 0.000 claims 1
- 108090001005 Interleukin-6 Proteins 0.000 claims 1
- 241000235058 Komagataella pastoris Species 0.000 claims 1
- 102100024640 Low-density lipoprotein receptor Human genes 0.000 claims 1
- 241000699666 Mus <mouse, genus> Species 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 102000015336 Nerve Growth Factor Human genes 0.000 claims 1
- 108010025020 Nerve Growth Factor Proteins 0.000 claims 1
- 241000235648 Pichia Species 0.000 claims 1
- 241000700159 Rattus Species 0.000 claims 1
- 238000001261 affinity purification Methods 0.000 claims 1
- 230000001270 agonistic effect Effects 0.000 claims 1
- 230000003321 amplification Effects 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 230000003042 antagnostic effect Effects 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 230000008236 biological pathway Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000003491 cAMP production Effects 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 238000010367 cloning Methods 0.000 claims 1
- 230000009089 cytolysis Effects 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 238000003306 harvesting Methods 0.000 claims 1
- 238000003018 immunoassay Methods 0.000 claims 1
- 238000001114 immunoprecipitation Methods 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 238000002826 magnetic-activated cell sorting Methods 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 239000002858 neurotransmitter agent Substances 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 claims 1
- 230000035899 viability Effects 0.000 claims 1
- 238000001262 western blot Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361791755P | 2013-03-15 | 2013-03-15 | |
| US61/791,755 | 2013-03-15 | ||
| PCT/US2014/030994 WO2014146074A2 (en) | 2013-03-15 | 2014-03-18 | Protocol for identifying and isolating antigen-specific b cells and producing antibodies to desired antigens |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016512044A JP2016512044A (ja) | 2016-04-25 |
| JP2016512044A5 true JP2016512044A5 (cg-RX-API-DMAC7.html) | 2017-04-20 |
| JP6466397B2 JP6466397B2 (ja) | 2019-02-06 |
Family
ID=51538609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502597A Expired - Fee Related JP6466397B2 (ja) | 2013-03-15 | 2014-03-18 | 抗原特異的ｂ細胞の同定及び単離ならびに所望の抗原に対する抗体作製のプロトコール |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20140287952A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2972330A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6466397B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20150140679A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2014232225B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2907570A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL241433B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014146074A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9255154B2 (en) | 2012-05-08 | 2016-02-09 | Alderbio Holdings, Llc | Anti-PCSK9 antibodies and use thereof |
| GB201316644D0 (en) | 2013-09-19 | 2013-11-06 | Kymab Ltd | Expression vector production & High-Throughput cell screening |
| CN111973740A (zh) | 2014-03-21 | 2020-11-24 | 泰华制药国际有限公司 | 针对降钙素基因相关肽的拮抗剂抗体及其使用方法 |
| US10556945B2 (en) | 2014-03-21 | 2020-02-11 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| EP3233916A4 (en) | 2014-12-19 | 2018-06-06 | Alder Biopharmaceuticals, Inc. | Humanized anti-acth antibodies and use thereof |
| US10934524B2 (en) | 2015-03-18 | 2021-03-02 | Epitomics, Inc. | High throughput monoclonal antibody generation by B cell panning and proliferation |
| US20190056398A1 (en) * | 2016-02-26 | 2019-02-21 | Sri International | Identification and isolation of antibodies from white blood cells |
| MX2018012470A (es) | 2016-04-15 | 2019-07-01 | Alder Biopharmaceuticals Inc | Anticuerpos anti pacap humanizados y usos de ellos. |
| CN109952314A (zh) | 2016-09-23 | 2019-06-28 | 泰瓦制药国际有限公司 | 治疗难治性偏头痛 |
| CA3045323A1 (en) | 2016-12-02 | 2018-06-07 | Juno Therapeutics, Inc. | Engineered b cells and related compositions and methods |
| WO2018133039A1 (zh) * | 2017-01-20 | 2018-07-26 | 深圳市新产业生物医学工程股份有限公司 | 制备抗体对的方法、试剂盒及试剂盒的应用和制备抗体对的系统 |
| US11125757B2 (en) | 2017-05-26 | 2021-09-21 | Emory University | Methods of culturing and characterizing antibody secreting cells |
| CN107058235B (zh) * | 2017-06-05 | 2020-08-11 | 深圳大学 | 一种b细胞筛选方法及其在单克隆抗体制备中的应用 |
| US20220243176A1 (en) * | 2019-05-31 | 2022-08-04 | The Penn State Research Foundation | Specific selection of immune cells using versatile display scaffolds |
| JP2023519782A (ja) * | 2020-01-17 | 2023-05-15 | ジャンプコード ゲノミクス，インク． | 標的化された配列決定の方法 |
| CN114441752B (zh) * | 2020-11-03 | 2024-11-26 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种筛选方法 |
| CN115166241B (zh) * | 2022-08-22 | 2023-03-24 | 广东忠信生物科技有限公司 | 一种同时筛选记忆b细胞和浆细胞的高效筛选技术及应用 |
| WO2025240335A1 (en) | 2024-05-13 | 2025-11-20 | Regeneron Pharmaceuticals, Inc. | Fgfr3 binding molecules and methods of use thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990000625A1 (en) * | 1988-07-14 | 1990-01-25 | Monoclonetics International, Inc. | Pre-screening for depletion and enrichment of specific b-cells |
| WO1992002551A1 (en) | 1990-08-02 | 1992-02-20 | B.R. Centre Limited | Methods for the production of proteins with a desired function |
| DK0488470T3 (da) * | 1990-11-26 | 1997-12-22 | Akzo Nobel Nv | Fremgangsmåde til fremstilling af antistoffer |
| US5213960A (en) * | 1992-03-09 | 1993-05-25 | Tanox Biosystems, Inc. | Methods for selecting low frequency antigen-specific single B lymphocytes |
| US5256542A (en) * | 1992-03-09 | 1993-10-26 | Tanox Biosystems, Inc. | Selecting low frequency antigen-specific single B lymphocytes with correction for background noise |
| US20050287607A1 (en) * | 2004-01-07 | 2005-12-29 | Diamond Betty A | Methods and compositions for identification of antigen-specific B cell populations |
| US20060051348A1 (en) | 2004-09-09 | 2006-03-09 | Jorn Gorlach | Method of producing a plurality of isolated antibodies to a plurality of cognate antigens |
| US7968308B2 (en) * | 2004-10-22 | 2011-06-28 | Danisco Us Inc. | Isolating human antibodies |
| EP1951337B1 (en) * | 2005-10-17 | 2018-08-01 | Gambro Lundia AB | Extracorporeal blood cleaning |
| EP2021463B1 (en) * | 2006-05-19 | 2016-11-23 | Alder Biopharmaceuticals, Inc. | Culture method for obtaining a clonal population of antigen-specific b cells |
| US20090191542A1 (en) * | 2006-08-23 | 2009-07-30 | Xcellerex, Inc. | Multi-variant cell indication technique |
| RU2459868C2 (ru) * | 2007-03-01 | 2012-08-27 | Симфоген А/С | Способ клонирования когнатных антител |
| CA3023889A1 (en) * | 2007-12-27 | 2009-07-09 | Abbott Laboratories | Anti-t. cruzi antibodies and methods of use |
| PL2400298T3 (pl) * | 2010-05-28 | 2014-01-31 | Hoffmann La Roche | Sposób hodowania pojedynczych komórek b oraz wytwarzania swoistych przeciwciał |
| EP2681237A1 (en) * | 2011-03-01 | 2014-01-08 | Novo Nordisk A/S | Antagonistic dr3 ligands |
| SG10201608341XA (en) * | 2011-11-23 | 2016-11-29 | Hoffmann La Roche | Cd40l expressing mammalian cells and their use |
| WO2013130462A1 (en) * | 2012-02-29 | 2013-09-06 | Medimmune, Llc | Antibody production methods |
-
2014
- 2014-03-18 EP EP14764593.1A patent/EP2972330A4/en not_active Withdrawn
- 2014-03-18 JP JP2016502597A patent/JP6466397B2/ja not_active Expired - Fee Related
- 2014-03-18 KR KR1020157028403A patent/KR20150140679A/ko not_active Abandoned
- 2014-03-18 WO PCT/US2014/030994 patent/WO2014146074A2/en not_active Ceased
- 2014-03-18 US US14/217,594 patent/US20140287952A1/en not_active Abandoned
- 2014-03-18 CA CA2907570A patent/CA2907570A1/en not_active Abandoned
- 2014-03-18 US US14/776,945 patent/US20160033504A1/en not_active Abandoned
- 2014-03-18 AU AU2014232225A patent/AU2014232225B2/en not_active Ceased
-
2015
- 2015-09-10 IL IL241433A patent/IL241433B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016512044A5 (cg-RX-API-DMAC7.html) | ||
| CN103869060B (zh) | 基于磁珠和微流控芯片的循环肿瘤干细胞检测试剂盒 | |
| JP2009537176A5 (cg-RX-API-DMAC7.html) | ||
| JP6466397B2 (ja) | 抗原特異的ｂ細胞の同定及び単離ならびに所望の抗原に対する抗体作製のプロトコール | |
| RU2577702C2 (ru) | 3d-facs-анализ-adcc nk-клеток | |
| US20100034807A1 (en) | Methods and compositions for discovery of target-specific antibodies using antibody repertoire array (ara) | |
| RU2014108048A (ru) | Способ обнаружения рака поджелудочной железы | |
| RU2016103262A (ru) | Способы идентификации иммунных связующих веществ поверхностных антигенов клетки | |
| EP2875819A1 (en) | Compositions of cardiomyocyte subpopulations | |
| Hsiao et al. | Development of a multiplexed assay for oral cancer candidate biomarkers using peptide immunoaffinity enrichment and targeted mass spectrometry | |
| HRP20230217T1 (hr) | Rep protein kao proteinski antigen za upotrebu u dijagnostičkim testovima | |
| RS61052B1 (sr) | Obogaćivanje cirkulišućih ćelija tumora osiromašenjem belih krvnih zrnaca | |
| CN110716053A (zh) | 检测群体反应性抗体的新方法 | |
| US20210063384A1 (en) | Method of assessing circulating tumor cells and method of using data obtained therefrom | |
| CN101324577A (zh) | 基质金属蛋白酶mmp11的血清学检测方法及用途 | |
| RU2017120228A (ru) | Особые моноклональные антитела антигена м метапневмовируса человека (hmpv) и способ их использования в методе диагностики | |
| WO2014096389A1 (en) | Method for identifying antibody producing cells | |
| CN110988325A (zh) | 封闭剂及包含该封闭剂的试剂盒 | |
| CN116003606B (zh) | 一种tigit纳米抗体及其制备方法与应用 | |
| CN115819595B (zh) | 一种抗lag3纳米抗体及其制备方法与应用 | |
| CN106353499A (zh) | 肺癌血清标志物适配体和基因同时检测试剂盒及应用 | |
| RU2009124225A (ru) | Мышиные моноклональные антитела, связывающиеся с антигеном f1 из yersinia pestis, способ их получения с использованием дрожжей, способ и набор для детекции yersinia pestis | |
| Jeong et al. | Enhanced detection of single-cell-secreted proteins using a fluorescent immunoassay on the protein-G-terminated glass substrate | |
| KR20150039054A (ko) | 시료 중 상피-중간엽 전환된 종양 세포를 확인하기 위한 정보를 얻는 방법, 시료 중 상피-중간엽 전환된 종양 세포를 확인하는 방법, 개체가 종양에 걸렸는지를 효율적으로 진단하는 방법, 및 시료 중 상피-중간엽 전환된 종양 세포를 확인하는데 사용하기 위한 조성물 또는 키트 | |
| CN106636329B (zh) | 一种检测哺乳动物血液中微量循环肿瘤细胞的特异性方法 |